Viruses 2010, 2(10), 2381-2403; doi:10.3390/v2102381
Review

Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections

1 Division of Infectious Diseases, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA 2 Infectious Diseases Section, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA 19104, USA
* Author to whom correspondence should be addressed.
Received: 19 September 2010; in revised form: 9 October 2010 / Accepted: 13 October 2010 / Published: 20 October 2010
(This article belongs to the Special Issue Antivirals Against Poxviruses)
PDF Full-text Download PDF Full-Text [101 KB, uploaded 20 October 2010 14:15 CEST]
Abstract: Despite the eradication of smallpox several decades ago, variola and monkeypox viruses still have the potential to become significant threats to public health. The current licensed live vaccinia virus-based smallpox vaccine is extremely effective as a prophylactic vaccine to prevent orthopoxvirus infections, but because of safety issues, it is no longer given as a routine vaccine to the general population. In the event of serious human orthopoxvirus infections, it is important to have treatments available for individual patients as well as their close contacts. The smallpox vaccine and vaccinia immune globulin (VIG) were used in the past as therapeutics for patients exposed to smallpox. VIG was also used in patients who were at high risk of developing complications from smallpox vaccination. Thus post-exposure vaccination and VIG treatments may again become important therapeutic modalities. This paper summarizes some of the historic use of the smallpox vaccine and immunoglobulins in the post-exposure setting in humans and reviews in detail the newer animal studies that address the use of therapeutic vaccines and immunoglobulins in orthopoxvirus infections as well as the development of new therapeutic monoclonal antibodies.
Keywords: orthopoxvirus; variola virus; vaccinia virus; monkeypox virus; post-exposure vaccination; Dryvax; Lister; modified vaccinia Ankara (MVA); vaccinia immune globulin (VIG); monoclonal antibodies

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Xiao, Y.; Isaacs, S.N. Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections. Viruses 2010, 2, 2381-2403.

AMA Style

Xiao Y, Isaacs SN. Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections. Viruses. 2010; 2(10):2381-2403.

Chicago/Turabian Style

Xiao, Yuhong; Isaacs, Stuart N. 2010. "Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections." Viruses 2, no. 10: 2381-2403.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert